ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 18.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $21,951 | -67.0% | 31,359 | -66.8% | 0.00% | – |
| Q4 2022 | $66,593 | -79.8% | 94,324 | -56.5% | 0.00% | -100.0% |
| Q3 2022 | $329,000 | -9.1% | 216,738 | -13.9% | 0.00% | 0.0% |
| Q1 2022 | $362,000 | -76.6% | 251,691 | -15.1% | 0.00% | -66.7% |
| Q4 2021 | $1,548,000 | +1910.4% | 296,543 | +2141.6% | 0.00% | – |
| Q3 2021 | $77,000 | -83.3% | 13,229 | -76.2% | 0.00% | -100.0% |
| Q1 2021 | $462,000 | -71.9% | 55,470 | -74.4% | 0.00% | -80.0% |
| Q4 2020 | $1,645,000 | +255.3% | 217,002 | +399.6% | 0.01% | +150.0% |
| Q3 2020 | $463,000 | +22.8% | 43,434 | +74.6% | 0.00% | 0.0% |
| Q2 2020 | $377,000 | -69.4% | 24,882 | -83.2% | 0.00% | -80.0% |
| Q1 2020 | $1,233,000 | +38.4% | 148,055 | +180.7% | 0.01% | +233.3% |
| Q4 2019 | $891,000 | – | 52,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 4,387,590 | $46,772,000 | 15.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,091,749 | $43,618,000 | 5.75% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,439,613 | $15,346,000 | 2.36% |
| Selkirk Management LLC | 348,805 | $3,718,000 | 1.18% |
| Chicago Capital, LLC | 1,966,891 | $20,967,000 | 1.08% |
| Trellus Management Company, LLC | 46,834 | $499,000 | 0.51% |
| Cannell & Co. | 1,118,439 | $11,923,000 | 0.44% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $1,652,000 | 0.36% |
| Belpointe Asset Management LLC | 419,406 | $3,982,000 | 0.27% |
| TCI Wealth Advisors, Inc. | 55,586 | $593,000 | 0.23% |